Buy Like Buffett
Watchlist

Flagship explainer

How AbbVie Inc. makes its money

Start with a dollar of revenue and follow what the filing says remains.

revenueBranching filed flows with values and percentages directly labeled. Missing filing concepts are omitted rather than estimated.Revenue$61.2B · 100%Cost of revenue$18.2B · 30%Gross profit$43.0B · 70%Operating income$15.1B · 25%Income before tax$6.6B · 11%Income tax$2.4B · 4%Net income$4.2B · 7%As of 2025-12-31 · 2 SEC filing sourcesBuy Like Buffett · buylikebuffett.com

Honest partial: the filing did not provide a normalized tag for Research and development, Selling, general and administrative; those components are omitted, not plugged.

Table alternative
Filed lineValue% of revenueSource
$61.2B100%
  • 10-K · FY 2025Filing detailsAccession 0001551152-26-000008 · filed Feb 20, 2026
Cost of revenue$18.2B30%
  • 10-K · FY 2025Filing detailsAccession 0001551152-26-000008 · filed Feb 20, 2026
$43.0B70%
  • 10-K · FY 2025Filing detailsAccession 0001551152-26-000008 · filed Feb 20, 2026
$15.1B25%
  • 10-K · FY 2025Filing detailsAccession 0001551152-26-000008 · filed Feb 20, 2026
Income before tax$6.6B11%
  • 10-K · FY 2025Filing detailsAccession 0001551152-26-000008 · filed Feb 20, 2026
Income tax$2.4B4%
  • 10-K · FY 2025Filing detailsAccession 0001551152-26-000008 · filed Feb 20, 2026
$4.2B7%
  • 10-K · FY 2025Filing detailsAccession 0001551152-26-000008 · filed Feb 20, 2026
Source:
  • 10-K · FY 2025Filing detailsAccession 0001551152-26-000008 · filed Feb 20, 2026
· event Dec 31, 2025 · retrieved Oct 16, 2026 · annual-row source set
Embed this chart

View the full AbbVie Inc. analysis at Buy Like Buffett